KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Revenue (TTM)
—
Q2 Jul 2015
Net Income (TTM)
−$107.92M
−7.8% YoY
Q2 Jul 2015
EPS Diluted (TTM)
−$1.18
+89.7% YoY
Q2 Jul 2015
Gross Margin
—
Q2 Jul 2015
Operating Margin
—
Q2 Jul 2015
Net Margin
—
Q2 Jul 2015
Free Cash Flow (TTM)
—
Q2 Jul 2015
Cash
$92.31M
Q2 Jul 2015
Total Debt
—
Q2 Jul 2015
Shares Outstanding
26.27M sh
Q2 Jul 2015
Revenue & Net Income
EPS (Diluted)
Revenue Growth (YoY)
No data available for this metric.